In respect to the anti-cancer properties of fenofibrate, activated PPARα, which is a transcriptional activator of the fatty acid β-oxidation machinery [16], could switch energy metabolism towards fatty acid degradation, and decrease glucose uptake by repressing glucose transporter GLUT4 [21,59]. The gene discussed is PPARA; the disease is cancer.